secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-031713
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel Q1 revenue up 30% to $68.4M, net loss narrows; raises FY revenue guidance to $326-336M
--------------------------------------------------------------------------------

- Total revenue up 30% to $68.4M; MACI revenue up 22% to $56.4M, Burn Care up 91% to $12.0M.
- Net loss narrowed to $6.3M from $11.2M; adjusted EBITDA up 195% to $9.6M (14% of revenue).
- Raised full-year 2026 revenue guidance by $10M to $326-336M; reaffirmed ~75% gross margin and ~27% adjusted EBITDA margin.
- Free cash flow of $15.1M; cash and investments $211M, no debt.
- Received FDA approval for MACI commercial manufacturing at new facility; BARDA award up to $197M for NexoBrid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000162828026031713/0001628280-26-031713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000162828026031713/vcel-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-031713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer